Paradigmdx
2 known investors
Paradigm develops diagnostic tests for cancer, including assessments of hereditary risk, screening for the presence of cancer, and analysis of the genomic alterations in a patient's tumor to help guide treatment decisions. The company operates in the cancer diagnostics and genomics industry.
Investors Β· 2
Frequently asked questions
- What does Paradigmdx do?
- Paradigm develops diagnostic tests for cancer, including assessments of hereditary risk, screening for the presence of cancer, and analysis of the genomic alterations in a patient's tumor to help guide treatment decisions. The company operates in the cancer diagnostics and genomics industry.
- Who are Paradigmdx's investors?
- Paradigmdx's investors include BlueStone Venture Partners, New Science Ventures.